Adjuvant radiation therapy after axillary lymphadenectomy for metastatic melanoma: Toxicity and local control

1995 ◽  
Vol 2 (5) ◽  
pp. 445-449 ◽  
Author(s):  
Eric A. Strom ◽  
Merrick I. Ross
Keyword(s):  
Radiation Therapy ◽  
Metastatic Melanoma ◽  
Local Control ◽  
Adjuvant Radiation ◽  
Adjuvant Radiation Therapy ◽  
Axillary Lymphadenectomy

scholarly journals Adjuvant Radiation Therapy Improved Local Control for Primary Mucosal Melanoma of the Head and Neck

2016 ◽  
Vol 96 (2) ◽  
pp. E384-E385 ◽  
Author(s):  
M. Abugideiri ◽  
K. Patel ◽  
J.M. Switchenko ◽  
K. Magliocca ◽  
Z.S. Buchwald ◽  
...  
Keyword(s):  
Radiation Therapy ◽  
Head And Neck ◽  
Local Control ◽  
Mucosal Melanoma ◽  
Adjuvant Radiation ◽  
Adjuvant Radiation Therapy

The benefits of adjuvant radiation therapy after therapeutic lymphadenectomy for clinically advanced, high-risk, lymph node-metastatic melanoma

Cancer ◽  
2009 ◽  
Vol 115 (24) ◽  
pp. 5836-5844 ◽  
Author(s):  
Shefali Agrawal ◽  
John M. Kane ◽  
Beverly A. Guadagnolo ◽  
William G. Kraybill ◽  
Matthew T. Ballo
Keyword(s):  
Radiation Therapy ◽  
Lymph Node ◽  
High Risk ◽  
Metastatic Melanoma ◽  
Adjuvant Radiation ◽  
Adjuvant Radiation Therapy

Multicentric randomized phase II trial of gamma knife surgery (GKS) versus image-guided, intensity-modulated radiation therapy (IG-IMRT) in patients with sacrococcygeal chordoma.

2017 ◽  
Vol 35 (15_suppl) ◽  
pp. 11033-11033
Author(s):  
Shun Lu ◽  
Jin Yi Lang ◽  
Weidong Wang ◽  
Mei Feng ◽  
Bingwen Zou ◽  
...  
Keyword(s):  
Overall Survival ◽  
Radiation Therapy ◽  
Surgical Resection ◽  
Local Control ◽  
High Recurrence Rate ◽  
Adjuvant Radiation ◽  
Adjuvant Radiation Therapy ◽  
Initial Surgery ◽  
First Choice ◽  
Significant Difference

11033 Background: Chordoma is a rare slow-growing neoplasm arisen from cellular remnants of the notochord. About 30% occur in the sacrococcygeal region. Surgical resection is recommended treatment. Due to the high recurrence rate, adjuvant radiation therapy was suggested to receive as an effective method to improve local control rates. Methods: Thirty eight patients were pathologically diagnosed as non-metastatic sacrococcygeal chordoma from Aug. 2003 to May. 2015 were recruited retrospectively to analysis. All patients received surgical resection after diagnosed. Initial surgery included subtotal resection (24% of patients), and gross total resection (76% of patients). Among these patients, 25 patients treated with adjuvant IG-IMRT, while 13 patients treated GKS after surgical resection. The median follow-up was 40 months (range, 6–151 month) for all patients, The PTV of IG-IMRT group received total doses were 60 Gy (range, 56-74Gy), delivered with 2-2.2 Gy/fraction, while GKS group underwent a total of 6-8 sessions treatment. Results: For the IG-IMRT group and the GKS group, the 5-year overall survival and local control rates were 87.5% and 67.7%, respectively. And 5-year local control rates were 35% and 22.2%, respectively. In total, 18 patients progressed locally: 11 were in the IG-IMRT group and 7 in the GKS group. In comparison with GKS group, the IG-IMRT group has a better overall recurrence-free survival (p = 0.03), the significance remained after adjusted for surgery results, age and gender. Moreover, there is no significant difference of overall survival was found between these two groups. Conclusions: We report favorable local control and adverse event rates following IG-IMRT, and suggested IG-IMRT is the first choice of adjuvant radiation therapy for sacrococcygeal chordoma treatment.

1059: Adjuvant Radiation Therapy Following Radical Prostatectomy for Adverse Pathology

2004 ◽  
Vol 171 (4S) ◽  
pp. 279-280
Author(s):  
Jonathan Rubenstein ◽  
Misop Han ◽  
Sheila A. Hawkins ◽  
William J. Catalona
Keyword(s):  
Radiation Therapy ◽  
Radical Prostatectomy ◽  
Adjuvant Radiation ◽  
Adjuvant Radiation Therapy

Fatigue in patients with adjuvant radiation therapy for breast cancer: long-term follow-up

2004 ◽  
Vol 130 (6) ◽  
pp. 327-333 ◽  
Author(s):  
Hans Geinitz ◽  
Frank B. Zimmermann ◽  
Reinhard Thamm ◽  
Monika Keller ◽  
Raymonde Busch ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Radiation Therapy ◽  
Adjuvant Radiation ◽  
Adjuvant Radiation Therapy ◽  
Long Term Follow Up

scholarly journals Radiation Therapy Improves Local Control in Juvenile Nasopharyngeal Angiofibroma following Disease Progression after Embolization and Surgical Resection: A Case Report

2021 ◽  
pp. 739-745
Author(s):  
Zane Blank ◽  
Richard Sleightholm ◽  
Beth Neilsen ◽  
Michael Baine ◽  
Chi Lin
Keyword(s):  
Radiation Therapy ◽  
Disease Progression ◽  
Surgical Resection ◽  
Local Control ◽  
Benign Neoplasm ◽  
Good Prognosis ◽  
Juvenile Nasopharyngeal Angiofibroma ◽  
Adjuvant Radiation ◽  
Nasopharyngeal Angiofibroma ◽  
Presenting Symptoms

Juvenile nasopharyngeal angiofibroma (JNA) is a relatively uncommon, benign neoplasm of the nasopharynx that can be very difficult to diagnose early due to inconspicuous and seemingly harmless presenting symptoms. Early diagnosis and treatment of JNA are essential for a good prognosis. JNA typically responds well to radiation therapy (RT), but when it does not, the most appropriate next course of action has not been readily defined due to the limited occurrence and experience with this neoplasm. Herein, we describe a JNA patient, who continued to progress after surgery and 36 Gy of adjuvant radiation, but after an additional 14.4 Gy, he has remained in remission for over 2 years. An 11-year-old boy who presented with JNA underwent treatment with embolization and surgical resection. Unfortunately, the tumor progressed within 2 months of surgical intervention and he required RT for adequate local control. While undergoing RT, he again demonstrated signs of progression; so his radiation regimen was increased from 3,600 cGy in 20 fractions to 5,040 cGy in 28 fractions. Since completing RT, the tumor has continued to decrease in size, and the patient is stable and has been without signs of disease progression for over 24 months now. Thus, escalating the radiation regimen to 5,040 cGy may improve local control in rapidly progressive JNA.

Adjuvant radiation therapy for stage II thymoma

2002 ◽  
Vol 74 (4) ◽  
pp. 1033-1037 ◽  
Author(s):  
Abeel A Mangi ◽  
Cameron D Wright ◽  
James S Allan ◽  
John C Wain ◽  
Dean M Donahue ◽  
...  
Keyword(s):  
Radiation Therapy ◽  
Stage Ii ◽  
Adjuvant Radiation ◽  
Adjuvant Radiation Therapy
Sign in / Sign up

Export Citation Format

Share Document